印度生物分析测试服务市场：按测试类型、按分子、按应用、按最终用户、按地区、机会、预测，2018-2032 年

印度生物分析测试服务市场规模预计从2025年到2032年将以10.70%的复合年增长率扩大，从2024年的9,035万美元增加到2032年的20,376万美元。庞大的患者群体使印度成为临床试验的理想地点，进一步推动了该国生物分析测试服务的成长。此外，生物技术公司数量的增加以及对生物製剂和生物相似药的需求不断增长预计也将在不久的将来推动市场成长。此外，这项服务的成本竞争力也是大多数全球製药公司外包其测试需求的驱动力。此外，政府对生命科学领域研究活动的举措和投资的增加预计将刺激生物分析测试服务在该国的采用。

在印度，政府的措施和不断发展的生物技术部门正在加强对药物发现的关注。促进製药和医疗技术研发（PRIP）计画与人工智慧和生成式人工智慧一起促进製药和医疗技术领域的研究和开发，实现更有效率的研究和降低药物开发成本。本公司也投资加强国内药物开发。例如，2023 年 12 月，Peptris Technologies Private Limited 从 Speciale Invest 筹集了 100 万美元的种子前资金。这项投资将支持人工智慧驱动的药物发现工作，重点是针对癌症、发炎和罕见疾病等无法治疗的标靶的新疗法。人工智慧的进步和庞大的化学库开闢了新的市场机会随着该国药物发现的加速，确保新疗法足够安全有效进入市场的生物分析的需求将迅速增加，从而支持市场成长。此外，学术界和工业界之间加强研究合作将进一步推动这一趋势，并使印度成为全球製药领域的关键参与者。

该报告考察了印度生物分析测试服务市场，并提供了市场概况，包括按测试类型、分子、应用、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第 4 章 2018-2032 年印度生物分析测试服务市场展望

• 市场规模分析与预测
• 市占率分析及预测
• 2024 年市场地图分析
  • 按考试类型
  • 按分子分类
  • 按用途
  • 按最终用户
  • 按地区

第5章供需分析

第6章 价值链分析

第7章 波特五力分析

第8章杵分析

第9章价格分析

第10章 市场动态

第11章 市场趋势与发展

第12章 监理框架与创新

第13章 专利情况

第14章案例研究

第15章 竞争格局

• 前5名市场领导者的竞争矩阵
• 前5名参与企业SWOT分析
• 前10名入市企业现状
  • Eurofins Biopharma Product Testing India Pvt Ltd
  • ICON plc
  • Thermo Fisher Scientific Inc
  • SGS India Private Limited
  • Charles River Laboratories International, Inc.
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • Vipragen Biosciences Pvt. Ltd.
  • Vimta Labs Ltd.

第16章 策略建议

第17章 查询及免责声明

India bioanalytical testing services market is projected to grow at a CAGR of 10.70% from FY2025 to FY2032, increasing from USD 90.35 million in FY2024 to USD 203.76 million by FY2032. Large patient populations have made India an ideal location for clinical trials, further fueling the growth of bioanalytical testing services in the country. In addition, an increasing number of biotechnology companies and rising demand for biologics and biosimilars will also promote market growth in the near future. Further, the cost-competitiveness of the service also acts as an impetus as it attracts outsourcing by most global pharmaceutical companies for their testing needs. Additionally, increased government initiatives and investments in the research activities of the life sciences sector are anticipated to fuel the adoption of bioanalytical testing services in the country.

India is increasingly focusing on drug discovery due to government initiatives and an ever-growing biotechnology sector. The Promotion of Research and Innovation in the Pharma MedTech Sector (PRIP) scheme promotes research and innovation in the Pharma MedTech sector along with AI and GenAI, thus promoting more efficient research and reduced costs for drug development. Companies are also investing in enhancing drug development in the country. For instance, in December 2023, Peptris Technologies Private Limited raised USD 1 million in pre-seed funding from Speciale Invest. This investment supports AI-driven drug discovery efforts focused on novel therapies for undruggable targets in oncology, inflammation, and rare diseases. Advances in AI and vast chemical libraries open new market opportunities. As drug discovery accelerates in the country, the need for bioanalytical testing services will surge to ensure new therapeutics are safe and effective enough to be put on the market, supporting market growth. Also, increased collaborations between academia and industry promote this trend and establish India as a key player in the global pharmaceutical landscape.

Expansion of Contract Research Organizations Impacts India Bioanalytical Testing Services Market

The rapid growth of India's pharmaceutical and biopharmaceutical industries significantly impacts the bioanalytical testing services market. Growing demand for drugs and biologics has pushed Contract Research Organizations (CROs) to expand their operations to keep pace with increasing demand for specialized testing, adopt cost-effective solutions, advance technology, and adhere to stringent regulatory standards. The collaborations between Indian CROs and pharmaceutical companies facilitate innovation and enhancement of service capabilities. These collaborations are imperative in providing holistic bioanalytical testing services, making India a significant global player. As such, growth in CROs directly enhances India's bioanalytical testing services market.

For instance, in November 2024, Bioneeds India Pvt Ltd. joined Contract Laboratory Network, strengthening its discovery, preclinical, and regulatory services across the domains. This acquisition would improve their market position and help accelerate the growth of bioanalytical testing services in India. Such a step would further follow the trend of overall growth in CRO, fostering collaborations, innovation, and opportunities within bioanalytical testing services, fueling further expansion and development in the industry.

Rising Demand for Biologics and Biosimilars Propels Market Growth

Increasing demand for biologics and biosimilars bolstered India's bioanalytical testing services market growth. Biologics are now more commonly used in chronic diseases like cancer and autoimmune diseases, for which biosimilars can be used more cost-effectively than biologics. Indian companies are also introducing new biologics and biosimilars to cater to the growing healthcare needs. This increased introduction will fuel the demand for bioanalytical testing services so that those products meet the set rigorous safety, efficacy, and regulatory standards. In addressing this demand, bioanalytical testing services have become a critical enabler for India's pharmaceutical industry in supporting its efforts to innovate and expand in biologics and biosimilars.

Pharmaceutical companies increased the number of new biosimilars in the market, which supported market growth. For instance, in January 2024, Glenmark Pharmaceuticals Ltd. launched a biosimilar of the anti-diabetic drug Liraglutide in India under the brand name 'Lirafit' after the Drug Controller General of India (DCGI) approval. All these launches increase the requirement for bioanalytical testing services in India to provide thorough testing and validation to ensure the efficacy and safety of newly launched biosimilars.

Pharmaceuticals and Biopharmaceuticals Companies Hold a Major Market Share

The pharmaceutical and biopharmaceutical companies hold the highest share in the Indian bioanalytical testing services market as they play the most crucial role in the development and manufacturing of drugs. These firms drive the market by investing in new biologics and biosimilars to cater to the domestic and international demand for advanced therapies. India's pharmaceutical giants are at the forefront of developing biosimilars for global markets. Their efforts also include pipeline development for monoclonal antibodies, vaccines, and other complex biologics that require stringent bioanalytical testing to comply with regulations. Indian firms' collaboration with international players also enhances the range of such testing services and provides easy access to state-of-the-art analytical technologies. For instance, in March 2024, Jubilant Biosys Ltd. expanded its presence in India and explored new therapeutic areas to provide drug discovery, development, and manufacturing services. It will keep pace with the ever-increasing demand for bioanalytical testing services, which is critical for maintaining Indian competitiveness in the global markets.

The growing emphasis on export-oriented biosimilar production also necessitates more extensive bioanalytical testing to meet the more stringent international regulatory requirements. Indian pharmaceutical companies are, therefore, partnering with specialized Contract Research Organizations (CROs) to outsource testing services, thereby enabling faster product development cycles with uncompromised quality. This collaboration between pharmaceutical companies and testing service providers strengthens India's position as a global hub for biologics and biosimilars and drives continuous innovation in methodologies for bioanalytical testing.

Future Market Scenario (FY2025-FY2032F)

The Indian bioanalytical testing market will experience significant growth in the coming years with development in AI, automation, and high throughput testing technologies. Pharmaceutical and biotechnology markets will grow because of policies such as "Make in India" and a focus on biosimilars. Thus, this will create an urgent demand for precise testing solutions. With growing clinical trials and research activities, there will be a growing demand for vaccines and biologics. Moreover, the increasing adoption of personalized medicine, stricter regulatory standards, and growing investments in health infrastructure also create opportunities for testing services.

For instance, the Indian pharmaceutical industry is increasing, providing high-value opportunities for bioanalytical testing services. With companies now focusing on innovative therapies, it is necessary to test with precision to confirm that the product is safe and effective. For instance, in August 2024, Amgen Inc., one of the biotech majors, established its technology and innovation center in Hyderabad, Telangana, called Amgen India. The facility will enhance the organization's digital capabilities globally and speed up Amgen's medicine pipeline.

Key Players Landscape and Outlook

Major players in the Indian bioanalytical testing services market are strengthening their footprints by enhancing R&D capabilities, forging strategic collaborations, and improving the testing infrastructure. They focus on diversified service portfolios catering to biosimilars, biologics, and personalized medicine. Moreover, companies are adopting advanced technologies and expanding their geographical reach to capture the growing demand from the pharmaceutical and biotechnology sectors, thereby providing sustained market growth in the following years.

In September 2023, Eurofins Scientific SE inaugurated its new bio-pharma services campus in Genome Valley in Hyderabad, which occupies one lakh sq ft of lab and office space. The facility strengthens its services in discovery chemistry, biology, toxicology, bio-analytical testing, and formulation development and is positioned to enhance its market share in India. This growth significantly increases market capacity regarding its service delivery, fosters innovation, and attracts pharmaceutical collaborations worldwide, thereby creating growth and development in the sector.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Bioanalytical Testing Services Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Test Type
    • 4.2.1.1. Pharmacokinetic Testing
    • 4.2.1.2. Pharmacodynamic Testing
    • 4.2.1.3. Biomarker Testing
    • 4.2.1.4. Virology Testing
    • 4.2.1.5. Serology testing
    • 4.2.1.6. Cell-based Assays
    • 4.2.1.7. Others
  • 4.2.2. By Molecule
    • 4.2.2.1. Small Molecule
    • 4.2.2.2. Large Molecule
  • 4.2.3. By Application
    • 4.2.3.1. Oncology
    • 4.2.3.2. Neurology
    • 4.2.3.3. Cardiology
    • 4.2.3.4. Infectious Diseases
    • 4.2.3.5. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Pharmaceutical and Biotechnology Companies
    • 4.2.4.2. Contract Research Organizations (CROs)
    • 4.2.4.3. Research and Academic Institutes
    • 4.2.4.4. Others
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. South
    • 4.2.5.3. East
    • 4.2.5.4. West & Central
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Test Type
  • 4.3.2. By Molecule
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Eurofins Biopharma Product Testing India Pvt Ltd
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 15.3.2. ICON plc
  • 15.3.3. Thermo Fisher Scientific Inc
  • 15.3.4. SGS India Private Limited
  • 15.3.5. Charles River Laboratories International, Inc.
  • 15.3.6. Intertek Group plc
  • 15.3.7. Laboratory Corporation of America Holdings
  • 15.3.8. Medpace, Inc.
  • 15.3.9. Vipragen Biosciences Pvt. Ltd.
  • 15.3.10. Vimta Labs Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Bioanalytical Testing Services Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Bioanalytical Testing Services Market Share (%), By Test Type, FY2018-FY2032F
• Figure 3. India Bioanalytical Testing Services Market Share (%), By Molecule, FY2018-FY2032F
• Figure 4. India Bioanalytical Testing Services Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Bioanalytical Testing Services Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Bioanalytical Testing Services Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Test Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Molecule Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024